ABDUL RAHMAN ALCHAKI: Open Payments
NPI 1821418666 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$99,589 in 129 payments from 13 companies in 2025. Trend: 2023 $761 · 2024 $14,976 · 2025 $99,589
Speaker / faculty: $87,228Travel & lodging: $7,595Food & beverage: $3,697Consulting: $1,013Education: $56
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 45 | $59,712 |
| TG Therapeutics, Inc. | 48 | $38,686 |
| Amgen Inc. | 12 | $367 |
| Biogen, Inc. | 4 | $232 |
| Novartis Pharmaceuticals Corporation | 7 | $170 |
| Alexion Pharmaceuticals, Inc. | 2 | $147 |
| ABBVIE INC. | 3 | $61 |
| PFIZER INC. | 3 | $61 |
| Celgene Corporation | 1 | $47 |
| Genentech, Inc. | 1 | $28 |
Products named: Mavenclad, BRIUMVI, UPLIZNA, KESIMPTA, VUMERITY, TYSABRI, NURTEC ODT, ZEPOSIA.
Industry payments across TX — which companies pay providers there.
